Innovative Tools for Digital Pathology: Automated ROI Detection and Image Patch Extraction
Read more
Velsera in a nutshell
Accelerate the scale up of your genetic testing & unlock the value in your data.
Bring new tests to market and scale up testing fast.
Accelerate your research breakgthroughs and novel drug launches.
Accelerate your research breakthroughs and unlock the value in your data.
Active clinical NGS lab customers
NGS samples sequences
Productized NGS assays available 'off the shelf'
Year over year sequencing volume
Top pharmas supported by our technology-enabled products and services
Researchers using the Seven Bridges Platform
Patients
Of multi-omic molecular data
Velsera solves problems by combining deep expertise with cutting edge tech
Our tertiary analytics & reporting tool for clinical NGS diagnostics.
Our best in class, IVD-grade variant interpretation knowledge base.
Our Trusted Research Environment (TRE) for bioinformatic analysis & pipeline development.
Our data harmonization and secure sharing platform.
Our award winning reference genome tool.
High throughput for PCR made simple.
Expert services
Services crafted to drive transformative advancements in healthcare
Supporting diagnostic labs to start and scale-up their NGS testing.
Supporting clinical diagnostic labs and diagnostic test developers to navigate the changing regulatory environment.
Supporting health & life science companies to combine and harmonize their data.
Supporting researchers and diagnostic developers to build better workflows
Supporting researchers to run efficient and effective studies.
Accelerate the scale up of your genetic testing & unlock the value in your data.
Develop better diagnostics that scale faster, accelerating novel drug uptake.
Use cutting edge technology to make new discoveries and breakthroughs faster.
Hear how leading life sciences companies and clinical diagnostic labs trust our technology to accelerate discovery and improve patient care.
Blog
On December 12, 2024 | By Jovan Babic
Read more
Blog
On October 29, 2024 | By Christopher Wilkinson
Read more
Blog
On October 10, 2024 | By Cates Mallaney
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Read more